(Q39955401)

English

An oncolytic adenovirus expressing granulocyte macrophage colony-stimulating factor shows improved specificity and efficacy for treating human solid tumors

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 September 2017

An oncolytic adenovirus expressing granulocyte macrophage colony-stimulating factor shows improved specificity and efficacy for treating human solid tumors (English)

1 reference

Europe PubMed Central

15 September 2017

0 references

oncolytic virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Colony stimulating factor 2

1 reference

based on heuristic

inferred from title

author name string

N Lei

1

1 reference

Europe PubMed Central

15 September 2017

F B Shen

2

1 reference

Europe PubMed Central

15 September 2017

J H Chang

3

1 reference

Europe PubMed Central

15 September 2017

L Wang

4

1 reference

Europe PubMed Central

15 September 2017

H Li

5

1 reference

Europe PubMed Central

15 September 2017

C Yang

6

1 reference

Europe PubMed Central

15 September 2017

J Li

7

1 reference

Europe PubMed Central

15 September 2017

D C Yu

8

1 reference

Europe PubMed Central

15 September 2017

publication date

1 August 2008

1 reference

Europe PubMed Central

15 September 2017

Cancer Gene Therapy

1 reference

Europe PubMed Central

15 September 2017

16

1 reference

Europe PubMed Central

15 September 2017

33-43

1 reference

Europe PubMed Central

15 September 2017

1

1 reference

Europe PubMed Central

15 September 2017

https://scigraph.springernature.com/pub.10.1038/cgt.2008.46

0 references

Development of transcriptionally regulated oncolytic adenoviruses

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.46

21 January 2018

Oncolytic adenovirus CG7870 in combination with radiation demonstrates synergistic enhancements of antitumor efficacy without loss of specificity

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.46

21 January 2018

A survey of telomerase activity in human cancer

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.46

21 January 2018

Telomerase-specific replication-selective virotherapy for human cancer

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.46

21 January 2018

Oncolysis and suppression of tumor growth by a GFP-expressing oncolytic adenovirus controlled by an hTERT and CMV hybrid promoter

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.46

21 January 2018

Noninvasive imaging of the transcriptional activities of human telomerase promoter fragments in mice

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.46

21 January 2018

Selective ablation of human cancer cells by telomerase-specific adenoviral suicide gene therapy vectors expressing bacterial nitroreductase

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.46

21 January 2018

Modulation of telomerase promoter tumor selectivity in the context of oncolytic adenoviruses.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.46

21 January 2018

Ad-mTERT-delta19, a conditional replication-competent adenovirus driven by the human telomerase promoter, selectively replicates in and elicits cytopathic effect in a cancer cell-specific manner

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.46

21 January 2018

An oncolytic adenovirus controlled by a modified telomerase promoter is attenuated in telomerase-negative cells, but shows reduced activity in cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.46

21 January 2018

CG0070, a conditionally replicating granulocyte macrophage colony-stimulating factor--armed oncolytic adenovirus for the treatment of bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.46

21 January 2018

Transcription of the E2F-1 gene is rendered cell cycle dependent by E2F DNA-binding sites within its promoter

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.46

21 January 2018

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.46

21 January 2018

Dual promoter-controlled oncolytic adenovirus CG5757 has strong tumor selectivity and significant antitumor efficacy in preclinical models

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.46

21 January 2018

Structure of the human Papillomavirus E7 oncoprotein and its mechanism for inactivation of the retinoblastoma tumor suppressor

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.46

21 January 2018

In vitro and in vivo activities of an oncolytic adenoviral vector designed to express GM-CSF.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.46

21 January 2018

Positive and negative regulation of cell proliferation by E2F-1: influence of protein level and human papillomavirus oncoproteins

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.46

21 January 2018

Novel immunocompetent murine tumor models for the assessment of replication-competent oncolytic adenovirus efficacy.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.46

21 January 2018

Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.46

21 January 2018

Telomerase-dependent gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.46

21 January 2018

Telomerase activation, cellular immortalization and cancer

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.46

21 January 2018

The E7 proteins of low- and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.46

21 January 2018

Triple-targeted oncolytic adenoviruses featuring the cox2 promoter, E1A transcomplementation, and serotype chimerism for enhanced selectivity for ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.46

21 January 2018

Treatment of ovarian cancer with a novel dual targeted conditionally replicative adenovirus (CRAd).

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.46

21 January 2018

New oncolytic adenoviruses with hypoxia- and estrogen receptor-regulated replication

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.46

21 January 2018

Telomerase maintains telomere structure in normal human cells.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.46

21 January 2018

A phase I trial of intravenous CG7870, a replication-selective, prostate-specific antigen-targeted oncolytic adenovirus, for the treatment of hormone-refractory, metastatic prostate cancer.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.46

21 January 2018

A phase-I trial using a universal GM-CSF-producing and CD40L-expressing bystander cell line (GM.CD40L) in the formulation of autologous tumor cell-based vaccines for cancer patients with stage IV disease

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.46

21 January 2018

GM-CSF gene-modifed cancer cell immunotherapies: of mice and men.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.46

21 January 2018

Differential cis-regulation of human versus mouse TERT gene expression in vivo: identification of a human-specific repressive element

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.46

21 January 2018

An improved helper-dependent adenoviral vector allows persistent gene expression after intramuscular delivery and overcomes preexisting immunity to adenovirus

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.46

21 January 2018

Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.46

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/CGT.2008.46

1 reference

Europe PubMed Central

15 September 2017

1 reference

Europe PubMed Central

15 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39955401&oldid=1880891444"